Management For The CNO Patients With Differentiated Thyroid Carcinoma

Thyroid carcinoma is the most common malignant tumor ofendocrine system.It contains differentiated thyroid carcinoma（DTC），low differentiated thyroid carcinoma such as medullarycarcinoma,and not differentiated thyroid carcinoma.Differentiatedthyroid carcinoma is a kind of low malignant thyroid tumor, whichconsists of papillary thyroid carcinoma（PTC）and follicular thyroidcarcinoma（FTC）.Although its prognosis is good, but because of thelymph node metastasis rate is high, by the clinician’s attention.Inrecent years, more and more data display, neck lymph nodemetastasis has become one of the important factors on thyroidcarcinoma prognosis.At present, the domestic and foreign scholarsfor differentiated thyroid cancer patients with cN0lymph nodes in theneck treatment has not yet reached an agreement.In this paper,288cases of differentiated thyroid cancer cN0patients were randomly divided into two groups in our hospitalbetween December2010to December2011.All patients wereperformed surgical treatment. A set of preventive neck lymph nodes(level Ⅵ) dissection，another group without lymph node dissection level Ⅵ.Contrast the two groups of operation time, bleeding volumein surgery， postoperative complications, postoperativerecovery.Summary of our cN0DTC patients level Ⅵ lymph nodemetastasis.Combined with postoperative pathological findings,judging the cN0patients and level Ⅵ lymph node metastasis inpatients.Provided necessary theoretical data for surgery cleaningthose patients with cN0of DTC.